Bionote USA Launches Vcheck C1 In-Clinic Chemistry Analyzer
- Bionote, USA
- Nov 13
- 2 min read
New diagnostic tool offers broad parameters and affordable pricing for over 30 species
BIG LAKE, MINN. (November 13, 2025) – Veterinary diagnostics company Bionote USA introduces the Vcheck C1, the most affordable chemistry analyzer on the veterinary market.
The Vcheck C1 is a compact biochemistry analyzer that enables simultaneous analysis of up to 24 test parameters from a small sample in minutes, ensuring high accuracy and efficiency.
Compatible test groups with the C1 include Electrolyte 14, Comprehensive 17, Avian Exotic 18, Liver Panel 11, Kidney Panel 10, Diabetes 9, Coagulation 4, Ammonia One and the Comprehensive 24, which delivers the widest chemistry profile available in its class. Testing can be completed in just 10-12 minutes, depending on the parameters, delivering laboratory-grade accuracy using a small sample and simple workflow.
The Vcheck C1 is also the only analyzer in the industry capable of supporting 34 species, each with individual, validated reference ranges. This allows veterinarians to test canine, feline, equine and bovine patients, plus 30 additional species of exotic animals, all with the same intuitive system.
The analyzer is also optimized for organ-specific testing, offering nine specialized rotor panels for testing without compromise. Panel pricing starts at just $12.95.
“At Bionote, we’re consistently working to elevate our product offerings and equip veterinarians with the tools they need to practice medicine the way they’ve always wanted. The addition of the C1 to our in-clinic diagnostic lineup gets us one step closer to achieving that goal,” said Bionote USA President Randy Knick. “Its broad chemistry range, multi-species calibration and targeted test panels help ensure faster diagnosis, reduce send-out costs and improve patient outcomes.”
The C1 joins Bionote’s Vcheck F series analyzers, the Vcheck V200 and V2400, to offer in-clinic diagnostics to veterinary practices. The F series provides quantitative results in minutes on critical biomarkers across canine, feline and equine care, and it is the only in-clinic analyzer on the market to offer both Canine and Feline quantitative europium immunoassay NT-proBNP testing.
For more information on the Vcheck C1, visit www.bionote.com/vcheck-c1. To learn more about Bionote’s other quantitative in-clinic analyzers and tests, visit www.bionote.com/veterinary-products.

Comments